SAN FRANCISCO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Arterys, the world's leading vendor neutral AI platform, today announced its partnership with Combinostics to make their AI imaging solution, cNeuro® ...
The Dementia Differential Analysis report visualizes comparisons of patient MRI biomarkers with data from patients with various types of dementia or normal cognition. TAMPERE, Finland--(BUSINESS WIRE) ...
TAMPERE, Finland--(BUSINESS WIRE)--Combinostics, provider of artificial intelligence (AI) technology to help radiologists, clinicians, and researchers make confident, evidence-based decisions for ...
Dr. Erik Post and Dr. Hans-Peter Huber join as Group Chief Financial Officer and Vice President of European Sales, respectively. TAMPERE, Finland--(BUSINESS WIRE)--#aihealthcare--Combinostics, the ...
Combinostics, a neurology technology company looking at everything from early detection and diagnosis to the ongoing management of neurological disorders, has announced the Dementia Differential ...
Tampere, Finland-based startup Combinostics, maker of data-driven clinical assessment software, has secured €3.9m in a Series A funding round led by Industrifonden and NordicNinja VC, it was announced ...
NAPLES, Fla., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Fountain Health is proud to officially announce 100 percent coverage of Combinostics cMRI™ and cDSI™ — the industry-leading AI-enabled neurological ...
CAMBRIDGE, Mass., April 27, 2023 /PRNewswire/ -- The Eureka Clinical AI platform, from ConcertAI's TeraRecon, now provides clinicians with the state-of-the-art artificial intelligence and deep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results